Ravi Kumar Chittoria
Vaibhav Shukla
Jacob Antony Chakiath
Amrutha J S
- Senior Professor and Associate Dean Department of Plastic Surgery and Telemedicine, JIPMER Puducherry India
- Junior Resident Department of General Surgery, JIPMER Puducherry India
- Senior Resident Department of Plastic Surgery, JIPMER Puducherry India
- Senior Resident Department of Plastic Surgery, JIPMER Puducherry India
Abstract
In clinical practice, chronic wounds are a major difficulty that are frequently made worse by the infection risk. However, the lack of precise standards for evaluating the risk of infection and establishing the need for and length of time for systemic antibiotics leads to the overuse and abuse of these drugs, which increases the risk of side effects and the development of antibiotic resistance. To close this gap, the development of a simple tool like the W.A.R. (Wound, Appearance, and Redness) score could completely transform how doctors make decisions. Taking into consideration variables including wound appearance and redness, which are suggestive of infection risk, the W.A.R. score provides a methodical way to assess chronic wounds. This tool gives clinicians the authority to decide when to start and how long to continue antimicrobial therapy by offering a consistent framework. The W.A.R. score helps doctors to prevent unnecessary antibiotic use by accurately predicting infection risk and allowing timely intervention when needed. Wide-ranging advantages may arise from using the W.A.R. score in clinical practice. Physicians would be more qualified to recognise patients who are more vulnerable to infection, allowing for more focused therapies to avoid problems. Additionally, by encouraging the prudent use of antibiotics, the W.A.R. score supports initiatives to counteract antimicrobial resistance, a concern to world health. Because of its simplicity of use, clinical decision-making procedures are streamlined, which eventually improves patient outcomes and maximises resource utilisation. Furthermore, the W.A.R. score promotes consistency and comparability among various healthcare settings and providers by standardising assessment criteria. To sum up, the development of the W.A.R. score is a noteworthy step forward in the treatment of chronic wounds. The W.A.R. score has the ability to completely transform clinical practice by offering a useful instrument for determining infection risk and directing choices about antimicrobial therapy. This could lead to improvements in patient safety, antimicrobial stewardship, and chronic wound outcomes.
Keywords: W.A.R., Score, Wound, prediction, Infection
[This article belongs to Emerging Trends in Personalized Medicines(etpm)]
Browse Figures
References
1. Reitan RL, McBroom RM, Gilder RE. The Risk of Infection and Indication of Systemic Antibiotics in Chronic Wounds. Wounds: a Compendium of Clinical Research and
Practice. 2020 Jul 1;32(7):186-94.
2. Chan BC. Economic Burden of Chronic Ulcers. University of Toronto (Canada); 2017.
3. Turi GK, Donovan V, DiGregorio J, Criscitelli TM, Kashan B, Barrientos S, Balingcongan JR, Gorenstein S, Brem H. Major histopathologic diagnoses of chronic wounds. Advances in Skin & Wound Care. 2016 Aug 1;29(8):376-82.
4. Rüttermann M, Maier-Hasselmann A, Nink-Grebe B, Burckhardt M. Local treatment of chronic wounds: in patients with peripheral vascular disease, chronic venous
insufficiency, and diabetes. Deutsches Ärzteblatt International. 2013 Jan;110(3):25.
5. Gürgen M. Excess use of antibiotics in patients with non-healing ulcers. EWMA J. 2014;14(1):17-22.
6. Dissemond J, Assadian O, Gerber V, Kingsley A, Kramer A, Leaper DJ, Mosti G, Piatkowski de Grzymala A, Riepe G, Risse A, Romanelli M. Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin pharmacology and physiology. 2011 Apr 20;24(5):245-55.
7. Lipsky BA, Dryden M, Gottrup F, Nathwani D, Seaton RA, Stryja J. Antimicrobial stewardship in wound care: a position paper from the British Society for Antimicrobial
Chemotherapy and European Wound Management Association. Journal of Antimicrobial Chemotherapy. 2016 Nov 1;71(11):3026-35.
8. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, Deery HG,Embil JM, Joseph WS, Karchmer AW, Pinzur MS. 2012 Infectious Diseases Society of
America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clinical infectious diseases. 2012 Jun 15;54(12):e132-73.
9. Game FL, Apelqvist J, Attinger CE, Hartemann A, Hinchliffe RJ, Löndahl M, Price PE,Jeffcoate WJ, International Working Group on the Diabetic Foot (IWGDF).
Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes/metabolism research and reviews. 2016 Jan;32:154-68.
10. Torkington-Stokes R, Metcalf D, Bowler P. Management of diabetic foot ulcers: evaluation of case studies. British Journal of Nursing. 2016 Aug 11;25(15):S27-33.
| Volume | 01 |
| Issue | 01 |
| Received | March 18, 2024 |
| Accepted | March 22, 2024 |
| Published | March 28, 2024 |